Medical Device Reimbursement Conference

Overcoming Challenges in Obtaining Reimbursement in Europe, Focusing on the Increasing Influence of HTA, Finding Value in DRG Payment Systems, and Understanding Nuances of Reimbursement in Individual Member States

May 18-19
Brussels, Belgium

Ensuring adequate coverage and reimbursement of a new medical technology is critical in assuring the successful commercialization of any new product, and is unfortunately not as easy as it may have once been. Heightened competition, converging European Union healthcare payment systems and the increased complexity of medical technology today all play a role in the challenges device companies currently face. Through major-market case studies, discussions on health technology assessments and reimbursement specialists, this conference will provide critical information for device companies commercializing their product in Europe.

Key Speakers & Session Will Include:

Health Technology Assessments at NICE: Methodologies for Reviewing and Evaluating Medical Technologies
Dr. Gillian Leng
Chief Operating Officer
NHS Evidence
Deputy Chief Executive
National Institute for Health & Clinical Excellence (NICE)

Impact of DRG Payment Systems on Medical Technology Reimbursement
Gabriela Soskuty
VP Government Affairs, Health Policy & Economics
B.Braun

Creating a Unified Strategy to Device Reimbursement in Europe
Adrian Griffin

VP Strategic Affairs

LifeScan EMEA

And Many More...

For full conference agenda, registration details, and information on promotional pricing please contact:
Paul Hernandez, Marketing Manager
phernandez@Q1productions.com
312-602-9684